Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for mitochondrial protection in pediatric cardiac surgery
NCT02299063Phase 4Unknown
- Sponsor
- SickKids
- Start
- Nov 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in ischemia-reperfusion injury (IRI), sponsored by SickKids. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT02299063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299063.